Pathophysiology and therapeutic potential of purinergic signaling

Pharmacological Reviews

Volumn 58, Issue 1, 2006, Pages 58-86

  Burnstock, Geoffrey ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

A 134974; A 317491; ACETYLSALICYLIC ACID; ADENOSINE A2 RECEPTOR ANTAGONIST; ADENOSINE KINASE INHIBITOR; ADENOSINE TRIPHOSPHATE; ADENOSINE TRIPHOSPHATE MAGNESIUM; ANTICOAGULANT AGENT; ANTISENSE OLIGONUCLEOTIDE; CAPTOPRIL; CLOPIDOGREL; DENUFOSOL; GLUTAMINE; ICOSAPENTAENOIC ACID; IMIDAPRIL; LETEPRINIM; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; MRS 2500; NUCLEOTIDASE; PROPENTOFYLLINE; PURINE DERIVATIVE; PURINE P2X3 RECEPTOR ANTAGONIST; PURINE P2Y12 RECEPTOR ANTAGONIST; PURINERGIC RECEPTOR BLOCKING AGENT; PURINERGIC RECEPTOR STIMULATING AGENT; SURAMIN; TETRAMETHYLPYRAZINE; TICLOPIDINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; URIDINE TRIPHOSPHATE;

ACUTE GRANULOCYTIC LEUKEMIA; ALLODYNIA; ALZHEIMER DISEASE; ATHEROSCLEROSIS; BRONCHITIS; CARDIOVASCULAR DISEASE; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; CHAGAS DISEASE; CHEST TIGHTNESS; CHINESE MEDICINE; CLINICAL TRIAL; COGNITIVE DEFECT; COLON CARCINOMA; COLON TUMOR; DERMATOLOGY; DIABETES MELLITUS; DRUG EFFICACY; DRUG SAFETY; DYSMENORRHEA; DYSPNEA; EAR DISEASE; ENTERITIS; ERECTILE DYSFUNCTION; ESOPHAGUS CANCER; EYE DISEASE; GASTROENTEROLOGY; GENITAL SYSTEM; GLOMERULONEPHRITIS; GRANULOMATOSIS; HEART FAILURE; HEART INFARCTION; HIRSCHSPRUNG DISEASE; HUMAN; HYPERTENSION; HYPOTHYROIDISM; IMMUNE SYSTEM; INFLAMMATION; ISCHEMIC HEART DISEASE; KIDNEY DISEASE; KIDNEY POLYCYSTIC DISEASE; LOWER RESPIRATORY TRACT INFECTION; LUNG NON SMALL CELL CANCER; MECONIUM ASPIRATION; MELANOMA; MIGRAINE; MUSCULOSKELETAL DISEASE; NEUROLOGY; NEUROPATHIC PAIN; NEUROPROTECTION; NEUROTOXICITY; NEUROTRANSMISSION; NONHUMAN; NOSE DISEASE; OBESITY; ONCOLOGY; OVERACTIVE BLADDER; PAIN; PANCREAS CARCINOMA; PARKINSON DISEASE; PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA; PATHOPHYSIOLOGY; PENIS ERECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; RAT STRAIN; RESPIRATORY TRACT DISEASE; RESTENOSIS; RETINA DETACHMENT; REVIEW; SARCOIDOSIS; SPINAL CORD INJURY; STOMACH ULCER; STROKE; THROMBOSIS; UPPER RESPIRATORY TRACT INFECTION; URETER DISEASE; URINARY TRACT INFECTION; UROGENITAL TRACT DISEASE; VASODILATATION;

ANIMALS; CARDIOVASCULAR DISEASES; ENDOCRINE SYSTEM; FEMALE UROGENITAL DISEASES; GASTROINTESTINAL TRACT; HUMANS; IMMUNE SYSTEM; INFLAMMATION; MALE UROGENITAL DISEASES; MUSCULOSKELETAL DISEASES; NEOPLASMS; NERVOUS SYSTEM DISEASES; RECEPTORS, PURINERGIC P2; RESPIRATORY TRACT DISEASES; SIGNAL TRANSDUCTION; SKIN;

EID: 33644607461     PISSN: 00316997     EISSN: 15210081     Source Type: Journal    
DOI: 10.1124/pr.58.1.5     Document Type: Review

References (520)

1. 2Y purinoceptors? Pharmacol Ther 64:445-475.
2. Abbracchio MP and Burnstock G (1998) Purinergic signalling: pathophysiological roles. Jpn J Pharmacol 78:113-145.
3. Abraham EH, Salikhova AY, and Rapaport E (2003) ATP in the treatment of advanced cancer. Curr Top Membr 54:415-452.
4. Adair TH (2005) Growth regulation of the vascular system: an emerging role for adenosine. Am J Physiol 289:R283-R296.
5. 7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia. Blood 99:706-708.
6. Adriaensen D and Timmermans JP (2004) Purinergic signalling in the lung: important in asthma and COPD? Curr Opin Pharmacol 4:207-214.
7. Agboh KC, Webb TE, Evans RJ, and Ennion SJ (2004) Functional characterization of a P2X receptor from Schistosoma mansoni. J Biol Chem 279:41650-41657.
8. Agresti C, Meomartini ME, Amadio S, Ambrosini E, Volonté C, Aloisi F, and Visentin S (2005) ATP regulates oligodendrocyte progenitor migration, proliferation and differentiation: involvement of metabotropic P2 receptors. Brain Res Brain Res Rev 48:157-165.
9. Agteresch HJ, Dagnelie PC, van den Berg JWO, and Wilson JH (1999) Adenosine triphosphate: established and potential clinical applications. Drugs 58:211-232.
10. Agteresch HJ, Dagnelie PC, van der Gaast A, Stijnen T, and Wilson JH (2000) Randomized clinical trial of adenosine 5′-triphosphate in patients with advanced non-small-cell lung cancer. J Natl Cancer Inst 92:321-328.
11. Agteresch HJ, van Rooijen MHC, van den Berg JWO, Minderman-Voortman GJ, Wilson JHP, and Dagnelie PC (2003) Growth inhibition of lung cancer cells by adenosine 5-triphosphate. Drug Dev Res 60:196-203.
12. Alavi AM, Dubyak GR, and Burnstock G (2001) Immunohistochemical evidence for ATP receptors in human dental pulp. J Dental Res 80:476-483.
13. Almeida T, Rodrigues RJ, de Mendonca A, Ribeiro JA, and Cunha RA (2003) Purinergic P2 receptors trigger adenosine release leading to adenosine A2a receptor activation and facilitation of long-term potentiation in rat hippocampal slices. Neuroscience 122:111-121.
14. Andersson K-E (1997) Emptying against outflow obstruction - pharmacological aspects. Scand J Urol Nephrol Suppl 184:77-84.
15. Andersson K-E (2002) Overactive bladder - pharmacological aspects. Scand J Urol Nephrol Suppl 210:72-81.
16. Andersson K-E and Hedlund P (2002) Pharmacologic perspective on the physiology of the lower urinary tract. Urology 60:13-20.
17. Antunes VR, Bonagamba LG, and Machado BH (2005) Hemodynamic and respiratory responses to microinjection of ATP into the intermediate and caudal NTS of awake rats. Brain Res. 1032:85-93.
18. 3-immunoreactive primary sensory neurons innervating lumbar intervertebral disc in rats. Brain Res 989:214-220.
19. Arreola J and Melvin JE (2003) A novel chloride conductance activated by extracellular ATP in mouse parotid acinar cells. J Physiol 547:197-208.
20. Baba T, Fukui M, Sakata S, Tashima T, Takeshita I, Nakamura T, and Inoue T (1989) Selective enhancement of intratumoural blood flow in malignant gliomas: experimental study in rats by intracarotid administration of adenosine or adenosine triphosphate. Acta Neurochir (Wien) 101:66-74.
21. Baharav E, Dubrosin A, Fishman P, Bar-Yehuda S, Halpren M, and Weinberger A (2002) Suppression of experimental zymosan-induced arthritis by intraperitoneal administration of adenosine. Drug Dev Res 57:182-186.
22. Bailey MA, Turner C, Hus-Citharel A, Marchetti J, Imbert-Teboul M, Milner P, Burnstock G, and Unwin R (2004) P2Y receptors present in the native and isolated rat glomerulus. Nephron Physiology 96:P79-P90.
23. 3 receptor subunit in rat sensory neurons reveals a significant role in chronic neuropathic and inflammatory pain. J Neurosci 22:8139-8147.
24. Beinart SC, Kolm P, Veledar E, Zhang Z, Mahoney EM, Bouin O, Gabriel S, Jackson J, Chen R, Caro J, et al. (2005) Long-term cost effectiveness of early and sustained dual oral antiplatelet therapy with clopidogrel given for up to one year after percutaneous coronary intervention: results from the clopidogrel for the reduction of events during observation (CREDO) trial. J Am Coll Cardiol 46:761-769.
25. Belhassen B, Fish R, Viskin S, Glick A, Glikson M, and Eldar M (2000) Adenosine-5′-triphosphate test for the noninvasive diagnosis of concealed accessory pathway. J Am Coll Cardiol 36:803-810.
26. Belhassen B and Pelleg A (1985) Adenosine triphosphate and adenosine: perspectives in the acute management of paroxysmal supraventricular tachycardia. Clin Cardiol 8:460-464.
27. 1 receptors in the atria of patients suffering from dilated cardiomyopathy. Electrophoresis 20:2059-2064.
28. Berti SL, Bonan CD, da Silva FL, Battastini AM, Sarkis JJ, and Wannmacher CM (2001) Phenylalanine and phenylpyruvate inhibit ATP diphosphohydrolase from rat brain cortex. Int J Dev Neurosci 19:649-653.
29. Bertrand PP (2003) ATP and sensory transduction in the enteric nervous system. Neuroscientist 9:243-260.
30. 3 subunit. J Physiol 551:309-322.
31. Bianco F, Fumagalli M, Pravettoni E, D'Ambrosi N, Volonte C, Matteoli M, Abbracchio MP, and Verderio C (2005) Pathophysiological roles of extracellular nucleotides in glial cells: differential expression of purinergic receptors in resting and activated microglia. Brain Res Brain Res Rev 48:144-156.
32. Birder LA (2005) More than just a barrier: urothelium as a drug target for urinary bladder pain. Am J Physiol 289:F489-F495.
33. Birder LA, Ruan H-Z, Chopra B, Xiang Z, Barrick S, Buffington CA, Roppolo JR, Ford APDW, de Groat WC, and Burnstock G (2004) Alterations in P2X and P2Y purinergic receptor expression in urinary bladder from normal cats and cats with interstitial cystitis. Am J Physiol 287:F1084-F1091.
34. Birk AV, Leno E, Robertson HD, Bolotina VM, and Szeto HH (2003) Interaction between ATP and catecholamines in stimulation of platelet aggregation. Am J Physiol 284:H619-H625.
35. Blackburn MR (2003) Too much of a good thing: adenosine overload in adenosine-deaminase-deficient mice. Trends Pharmacol Sci 24:66-70.
36. Bland-Ward PA and Humphrey PPA (1997) Acute nociception mediated by hindpaw P2X receptor activation in the rat. Br J Pharmacol 122:365-371.
37. Blaug S, Rymer J, Jalickee S, and Miller SS (2003) P2 purinoceptors regulate calcium-activated chloride and fluid transport in 31eg4 mammary epithelia. Am J Physiol 284:C897-C909.
38. Bleehen T and Keele CA (1977) Observations on the algogenic actions of adenosine compounds on human blister base preparation. Pain 3:367-377.
39. Boeynaems JM, van Giezen H, Savi P, and Herbert JM (2005) P2Y receptor antagonists in thrombosis. Curr Opin Investig Drugs 6:275-282.
40. Boeynaems J-M, Robaye B, Janssens R, Suarez-Huerta N, and Communi D (2001) Overview of P2Y receptors as therapeutic targets. Drug Dev Res 52:187-189.
41. Bonan CD, Roesler R, Quevedo J, Battastini AM, Izquierdo I, and Sarkis JJ (1999) Effects of suramin on hippocampal apyrase activity and inhibitory avoidance learning of rats. Pharmacol Biochem Behav 63:153-158.
42. Borna C, Wang L, Gudbjartsson T, Karlsson L, Jern S, Malmsjo M, and Erlinge D (2003) Contractions in human coronary bypass vessels stimulated by extracellular nucleotides. Ann Thorac Surg 76:50-57.
43. Boselli C, Govoni S, Condino AM, and D'Agostino G (2001) Bladder instability: a re-appraisal of classical experimental approaches and development of new therapeutic strategies. J Auton Pharmacol 21:219-229.
44. 2+ mobilization is strongly potentiated by a parathyroid hormone/cAMP-dependent protein kinase pathway independently of mitogen-activated protein kinase. J Biol Chem 274:14315-14324.
45. Bowser DN and Khakh BS (2004) ATP excites interneurons and astrocytes to increase synaptic inhibition in neuronal networks. J Neurosci 24:8606-8620.
46. Boyle DL, Moore J, Yang L, Sorkin LS, and Firestein GS (2002) Spinal adenosine receptor activation inhibits inflammation and joint destruction in rat adjuvant-induced arthritis. Arthritis Rheum 46:3076-3082.
47. 3 purinoceptors in sensory neurons: effects of axotomy and glial-derived neurotrophic factor. Mol Cell Neurosci 12:256-268.
48. Brambilla R, Burnstock G, Bonazzi A, Ceruti S, Cattabeni F, and Abbracchio MP (1999) Cyclooxygenase-2 mediates P2Y receptor-induced reactive astrogliosis: special report. Br J Pharmacol 126:563-567.
49. Broadley KJ (2000) Drugs modulating adenosine receptors as potential therapeutic agents for cardiovascular diseases. Exp Opin Ther Patents 10:1169-1692.
50. Brockhaus J, Dressel D, Herold S, and Deitmer JW (2004) Purinergic modulation of synaptic input to Purkinje neurons in rat cerebellar brain slices. Eur J Neurosci 19:2221-2230.
51. 2 in the evaluation and treatment of children with pulmonary hypertension secondary to congenital heart defects. Circulation 90:1287-1293.
52. 3 receptors. Am J Respir Cell Mol Biol 23:52-61.
53. Brouns I, Van Genechten J, Hayashi H, Gajda M, Gomi T, Burnstock G, Timmermans J-P, and Adriaensen D (2003) Dual sensory innervation of pulmonary neuroepithelial bodies. Am J Respir Cell Mol Biol 28:275-285.
54. Bruno AN, Pochmann D, Riacachenevsky FK, Bonan CD, Barreto-Chaves MLM, and Sarkis JJF (2005a) 5′-Nucleotidase activity is altered by hypo-hyperthyroidism in platelets from adult rats. Platelets 16:25-30.
55. Bruno AN, Riacachenevsky FK, Pochmann D, Bonan CD, Battastini AMO, Barreto-Chaves MLM, and Sarkis JJF (2005b) Hypothyroidism changes adenine nucleotide hydrolysis in synaptosomes from hippocampus and cerebral cortex of rats in different phases of development. Int J Dev Neurosci 23:37-44.
56. Bucheimer RE and Linden J (2004) Purinergic regulation of epithelial transport. J Physiol 555:311-321.
57. 2/3 receptors by 2′,3′-O-(2,4,6-trinitrophenyl) adenosine 5′-triphosphate (TNP-ATP). Mol Pharmacol 58:1502-1510.
58. Burnstock G (1972) Purinergic nerves. Pharmacol Rev 24:509-581.
59. Burnstock G (1978) A basis for distinguishing two types of purinergic receptor, in Cell Membrane Receptors for Drugs and Hormones: A Multidisciplinary Approach (Straub RW and Bolis L eds) pp 107-118, Raven Press, New York.
60. Burnstock G (1981) Pathophysiology of migraine: a new hypothesis. Lancet i:1397-1399.
61. Burnstock G (1989) The role of adenosine triphosphate in migraine. Biomed Pharmacother 43:727-736.
62. Burnstock G (1996a) Purinoceptors: ontogeny and phylogeny. Drug Dev Res 39:204-242.
63. Burnstock G (1996b) A unifying purinergic hypothesis for the initiation of pain. Lancet 347:1604-1605.
64. Burnstock G (1999) Release of vasoactive substances from endothelial cells by shear stress and purinergic mechanosensory transduction. J Anat 194:335-342.
65. Burnstock G (2001a) Purinergic signalling in development, in Handbook of Experimental Pharmacology, Purinergic and Pyrimidinergic Signalling I - Molecular, Nervous and Urinogenitary System Function (Abbracchio MP and Williams M eds) vol 151, part I, pp 89-127, Springer-Verlag, Berlin.
66. Burnstock G (2001b) Purinergic signalling in gut, in Handbook of Experimental Pharmacology, Purinergic and Pyrimidinergic Signalling II - Cardiovascular, Respiratory, Immune, Metabolic and Gastrointestinal Tract Function (Abbracchio MP and Williams M eds), vol 151, part II, pp 141-238, Springer-Verlag, Berlin.
67. Burnstock G (2001c) Purine-mediated signalling in pain and visceral perception. Trends Pharmacol Sci 22:182-188.
68. Burnstock G (2001d) Overview of P2 receptors: possible functions in immune cells. Drug Dev Res 53:53-59.
69. Burnstock G (2001e) Purinergic signalling in lower urinary tract, in Handbook of Experimental Pharmacology, Purinergic and Pyrimidinergic Signalling I - Molecular, Nervous and Urinogenitary System Function (Abbracchio MP and Williams M eds) vol 151, part I, pp 423-515, Springer-Verlag, Berlin.
70. Burnstock G (2002a) Purinergic signalling and vascular cell proliferation and death. Arterioscler Thromb Vasc Biol 22:364-373.
71. Burnstock G (2002b) Potential therapeutic targets in the rapidly expanding field of purinergic signalling. Clin Med 2:45-53.
72. Burnstock G (2003a) Introduction: ATP and its metabolites as potent extracellular agents. Curr Top Membr 54:1-27.
73. Burnstock G (2003b) Purinergic receptors in the nervous system. Curr Top Membr 54:307-368.
74. Burnstock G (2004) Cotransmission. Curr Opin Pharmacol 4:47-52.
75. Burnstock G, Campbell G, Satchell D, and Smythe A (1970) Evidence that adenosine triphosphate or a related nucleotide is the transmitter substance released by non-adrenergic inhibitory nerves in the gut. Br J Pharmacol 40:668-688.
76. 2-purinoceptor? Gen Pharmacol 16:433-440.
77. Burnstock G and Knight GE (2004) Cellular distribution and functions of P2 receptor subtypes in different systems. Int Rev Cytol 240:31-304.
78. Burnstock G and Lavin S (2002) Interstitial cells of cajal and purinergic signalling. Auton Neurosci 97:68-72.
79. Burnstock G and Ralevic V (1994) New insights into the local regulation of blood flow by perivascular nerves and endothelium. Br J Plast Surg 47:527-543.
80. Burnstock G and Williams M (2000) P2 purinergic receptors: modulation of cell function and therapeutic potential. J Pharmacol Exp Ther 295:862-869.
81. Burnstock G and Wood JN (1996) Purinergic receptors: their role in nociception and primary afferent neurotransmission. Curr Opin Neurobiol 6:526-532.
82. 4 receptors. J Investig Dermatol 120:440-447.
83. Cain DM, Wacnik PW, Eikmeier L, Beitz A, Wilcox GL, and Simone DA (2001) Functional interactions between tumor and peripheral nerve in a model of cancer pain in the mouse. Pain Med 2:15-23.
84. 2 on experimental spinal cord injury. Neurosurg Rev 26:67-70.
85. Calvert RC, Shabbir M, Thompson CS, Mikhailidis DP, Morgan R, and Burnstock G (2004) Immunocytochemical and pharmacological characterisation of P2-purinoceptor-mediated cell growth and death in PC-3 hormone refractory prostate cancer cells. Anticancer Research 24:2853-2859.
86. CAPRIE Steering Committee (2001) A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events. Lancet 348:1329-1339.
87. 7 receptor activation-induced contraction and lysis in human saphenous vein smooth muscle. Circ Res 83:196-203.
88. 1 receptor. Biochem Pharmacol 68:1995-2002.
89. 4 receptor and ischemic cell death: prevention by P2 antagonists. Neuroscience 120:85-98.
90. 4 receptor participates in the commitment to differentiation and cell death of human neuroblastoma SH-SY5Y cells. Neurobiol Dis 18:100-109.
91. Chen CC, Akopian AN, Sivilotti L, Colquhoun D, Burnstock G, and Wood JN (1995) A P2X purinoceptor expressed by a subset of sensory neurons. Nature (Lond) 377:428-431.
92. Chen L, He H-Y, Li H-M, Zheng J, Heng W-J, You J-F and Fang W-G (2004) ERK1/2 and p38 pathways are required for P2Y receptor-mediated prostate cancer invasion. Cancer Letts 215:239-247.
93. 2 receptors. Glia 22:360-370.
94. 2 on ischemia-reperfusion lung injury is leukocyte dependent. J Biomed Sci 10:725-730.
95. 7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain. Pain 114:386-396.
96. Chess-Williams R (2004) Potential therapeutic targets for the treatment of detrusor overactivity. Expert Opin Ther Targets 8:95-106.
97. Chizh BA and Illes P (2000) P2X receptors and nociception. Pharmacol Rev 53:553-568.
98. 2+ mobilization and COX-2 in human microglia. Glia 43:95-103.
99. 2 receptors activate neuroprotective mechanisms in astrocytic cells. J Neurochem 91:119-132.
100. Churchill PC and Ellis VR (1993) Purinergic P2y receptors stimulate renin secretion by rat renal cortical slices. J Pharmacol Exp Ther 266:160-163.
101. 3-deficient mice. Nature (Lond) 407:1011-1015.
102. Collier HO, James GWL, and Schneider C (1966) Antagonism by aspirin and fenamates of bronchoconstriction and nociception induced by adenosine-5′- triphosphate. Nature (Lond) 212:411-412.
103. 6 receptors and the distribution and properties of an extended family of ATP-gated ion channels. J Neurosci 16:2495-2507.
104. 7 receptors activates three different ionic conductances on cultured mouse Schwann cells. Eur J Neurosci 14:927-936.
105. Conigrave AD, van der Weyden L, Holt L, Jiang L, Wilson P, Christopherson RI, and Morris MB (2000) Extracellular ATP-dependent suppression of proliferation and induction of differentiation of human HL-60 leukemia cells by distinct mechanisms. Biochem Pharmacol 60:1585-1591.
106. Cook PW, Ashton NM, and Pittelkow MR (1995) Adenosine and adenine nucleotides inhibit the autonomous and epidermal growth factor-mediated proliferation of cultured human keratinocytes. J Investig Dermatol 104:976-981.
107. Cooke HJ, Wunderlich J, and Christofi FL (2003) "The force be with you": ATP in gut mechanosensory transduction. News Physiol Sci 18:43-49.
108. Costessi A, Pines A, D'Andrea P, Romanello M, Damante G, Cesaratto L, Quadrifoglio F, Moro L, and Tell G (2005) Extracellular nucleotides activate Runx2 in the osteoblast-like HOBIT cell line: a possible molecular link between mechanical stress and osteoblasts' response. Bone 36:418-432.
109. Coutinho-Silva R, Parsons M, Robson T, and Burnstock G (2001) Changes in expression of P2 receptors in rat and mouse pancreas during development and aging. Cell Tissue Res 306:373-383.
110. Coutinho-Silva R, Parsons M, Robson T, Lincoln J, and Burnstock G (2003) P2X and P2Y purinoceptor expression in pancreas from streptozotocin-diabetic rats. Mol Cell Endocrinol 204:141-154.
111. Dagnelie PC and Agteresch HJ (2004) Promising effects of adenosine triphosphate infusion on nutritional status and quality of life in advanced non-small-cell lung cancer: a randomized clinical trial. Drug Dev Res 59:146-151.
112. Dang K, Bielfeldt K, Lamb K, and Gebhart GF (2005) Gastric ulcers evoke hyper-excitability and enhance P2X receptor function in rat gastric sensory neurons. J Neurophysiol 93:3112-3119.
113. 7 gene with familial forms of chronic lymphocytic leukaemia. Br J Haematol 125:815-817.
114. Davalos D, Grutzendler J, Yang G, Kim JV, Zuo Y, Jung S, Littman DR, Dustin ML, and Gan WB (2005) ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci 8:752-758.
115. Davis IC, Sullender WM, Hickman-Davis JM, Lindsey JR, and Matalon S (2004) Nucleotide-mediated inhibition of alveolar fluid clearance in BALB/c mice after respiratory syncytial virus infection. Am J Physiol 286:L112-L120.
116. De Paula PM, Antunes VR, Bonagamba LG, and Machado BH (2004) Cardiovascular responses to microinjection of ATP into the nucleus tractus solitarii of awake rats. Am J Physiol 287:R1164-R1171.
117. 7 ATP receptor inhibitor, oxidized ATP. Arthritis Rheum 46:3378-3385.
118. 7 antagonist, oxidized ATP, in arthritic rats. Neurosci Lett 327:87-90.
119. Denda M, Inoue K, Fuziwara S, and Denda S (2002) P2X purinergic receptor antagonist accelerates skin barrier repair and prevents epidermal hyperplasia induced by skin barrier disruption. J Investig Dermatol 119:1034-1040.
120. Dhalla AK, Shryock JC, Shreeniwas R, and Belardinelli L (2003) Pharmacology and therapeutic applications of A1 adenosine receptor ligands. Curr Top Med Chem 3:369-385.
121. Di Virgilio F, Chiozzi P, Ferrari D, Falzoni S, Sanz JM, Morelli A, Torboli M, Bolognesi G, and Baricordi OR (2001) Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood 97:587-600.
122. 7 receptor: a pivotal role in inflammation and immunomodulation. Drug Dev Res 45:207-213.
123. Di Virgilio F and Solini A (2002) P2 receptors: new potential players in atherosclerosis. Br J Pharmacol 135:831-842.
124. 2 receptors. Br J Pharmacol 127:1680-1686.
125. Dixon SJ and Sims SM (2000) P2 purinergic receptors on osteoblasts and osteoclasts: potential targets for drug development. Drug Dev Res 49:187-200.
126. Dorn G, Patel S, Wotherspoon G, Hemmings-Mieszczak M, Barclay J, Natt FJ, Martin P, Bevan S, Fox A, Ganju P, et al. (2004) SiRNA relieves chronic neuropathic pain. Nucleic Acids Res 32:e49.
127. Dranoff JA, Ogawa M, Kruglov EA, Gaca MD, Sevigny J, Robson SC, and Wells RG (2004) Expression of P2Y nucleotide receptors and ectonucleotidases in quiescent and activated rat hepatic stellate cells. Am J Physiol 287:G417-G424.
128. Drury AN and Szent-Györgyi A (1929) The physiological activity of adenine compounds with special reference to their action upon the mammalian heart. J Physiol (Lond) 68:213-237.
129. Dubyak GR and El Moatassim C (1993) Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides. Am J Physiol 265:C577-C606.
130. + T lymphocytes. J Immunol 169:15-21.
131. Dunn PM (2000) Fertility: purinergic receptors and the male contraceptive pill. Curr Biol 10:R305-R307.
132. Dunn PM, Zhong Y, and Burnstock G (2001) P2X receptors in peripheral neurones. Prog Neurobiol 65:107-134.
133. Edwards FA, Gibb AJ, and Colquhoun D (1992) ATP receptor-mediated synaptic currents in the central nervous system. Nature (Lond) 359:144-147.
134. 2+ signaling in human chondrons cultured in three-dimensional agarose films. Osteoarthritis Cartilage 9:518-526.
135. Eltzschig HK, Ibla JC, Furuta GT, Leonard MO, Jacobson KA, Enjyoji K, Robson SC, and Colgan SP (2003) Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors. J Exp Med 198:783-796.
136. Enjyoji K, Sevigny J, Lin Y, Frenette PS, Christie PD, Esch JS 2nd, Imai M, Edelberg JM, Rayburn H, Lech M, et al. (1999) Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nat Med 5:1010-1017.
137. Erlinge D, Hou M, Webb TE, Barnard EA, and Moller S (1998) Phenotype changes of the vascular smooth muscle cell regulate P2 receptor expression as measured by quantitative RT-PCR. Biochem Biophys Res Commun 248:864-870.
138. Essien EM and White AG (1998) Elevated plasma adenosine triphosphate (ATP) concentration in human acute malaria infection. Thromb Haemost 80:867-868.
139. Evans RJ, Derkach V, and Surprenant A (1992) ATP mediates fast synaptic transmission in mammalian neurons. Nature (Lond) 357:503-505.
140. Exley C and Korchazhkina OV (2001) Promotion of formation of amyloid fibrils by aluminium adenosine triphosphate (AlATP). J Inorg Biochem 84:215-224.
141. 3) receptors in Hirschsprung's intestine. J Pediatr Surg 36:1679-1684.
142. 7-dependent process inducing bacterial death by phagosome-lysosome fusion. J Immunol 167:3300-3307.
143. s-coupled receptor. J Immunol 173:7539-7547.
144. Feoktistov I and Biaggioni I (1996) Role of adenosine in asthma. Drug Dev Res 39:333-336.
145. Feranchac AP and Fitz JG (2003) Purinergic receptors and hepatobiliary function. Curr Top Membr 54:395-414.
146. Ferguson DR and Christopher N (1996) Urinary bladder function and drug development. Trends Pharmacol Sci 17:161-165.
147. Ferguson DR, Kennedy I, and Christopher N (1997) ATP is released from rabbit urinary bladder epithelial cells by hydrostatic pressure changes-a possible sensory mechanism? J Physiol (Lond) 505:503-511.
148. Ferrari D, Munerati M, Melchiorri L, Hanau S, Di Virgillio F, and Baricordi OR (1994) Responses to extracellular ATP of lymphoblastoid cell lines from Duchenne muscular dystrophy patients. Am J Physiol 267:C886-C892.
149. Fields RD and Stevens B (2000) ATP: an extracellular signaling molecule between neurons and glia. Trends Neurosci 23:625-633.
150. Fields RD and Stevens-Graham B (2002) New insights into neuron-glia communication. Science (Wash DC) 298:556-562.
151. Flier JS (1995) The adipocyte: storage depot or node on the energy information superhighway? Cell 80:15-18.
152. 2 purinergic receptors in precerebellar nuclei. Neuroscience 115:425-434.
153. 12 gene sequence variations in healthy subjects. Circulation 108:989-995.
154. Fozard JR and McCarthy C (2002) Adenosine receptor ligands as potential therapeutics in asthma. Curr Opin Investig Drugs 3:69-77.
155. Fredholm BB (1981) Adenosine and lipolysis. Int J Obes 5:643-649.
156. Fredholm BB, Abbracchio MP, Burnstock G, Daly JW, Harden TK, Jacobson KA, Leff P, and Williams M (1994) Nomenclature and classification of purinoceptors. Pharmacol Rev 46:143-156.
157. Fredholm BB, Chen JF, Masino SA, and Vaugeois JM (2005) Actions of adenosine at its receptors in the CNS: insights from knockouts and drugs. Ann Rev Pharmacol Toxicol 45:385-412.
158. 2A receptors and therapeutic applications. Curr Topics Med Chem 3:413-426.
159. Fry CH, Ikeda Y, Harvey R, Wu C, and Sui GP (2004) Control of bladder function by peripheral nerves: avenues for novel drug targets. Urology 63:24-31.
160. Fujii S, Kato H, and Kuroda Y (1999) Extracellular adenosine 5′-triphosphate plus activation of glutamatergic receptors induces long-term potentiation in CA1 neurons of guinea pig hippocampal slices. Neurosci Lett 276:21-24.
161. Fujii S, Kato H, and Kuroda Y (2002) Cooperativity between extracellular adenosine 5′-triphosphate and activation of N-methyl-D-aspartate receptors in long-term potentiation induction in hippocampal CA1 neurons. Neuroscience 113:617-628.
162. Funk GD, Kanjhan R, Walsh C, Lipski J, Comer AM, Parkis MA, and Housley GD (1997) P2 receptor excitation of rodent hypoglossal motoneuron activity in vitro and in vivo: a molecular physiological analysis. J Neurosci 17:6325-6337.
163. Gaba SJ, Bourgouin-Karaouni D, Dujols P, Michel FB, and Prefaut C (1986) Effects of adenosine triphosphate on pulmonary circulation in chronic obstructive pulmonary disease. ATP: a pulmonary vasoregulator? Am Rev Respir Dis 134:1140-1144.
164. Gachet C (2001) ADP receptors of platelets and their inhibition. Thromb Haemost 86:222-232.
165. Gale JE, Piazza V, Ciubotaru CD, and Mammano F (2004) A mechanism for sensing noise damage in the inner ear. Curr Biol 14:526-529.
166. Galligan JJ (2002) Pharmacology of synaptic transmission in the enteric nervous system. Curr Opin Pharmacol 2:623-629.
167. Galligan JJ (2004) Enteric P2X receptors as potential targets for drug treatment of the irritable bowel syndrome. Br J Pharmacol 141:1294-1302.
168. 7 receptor by a subpopulation of human osteoblasts. J Bone Miner Res 16:846-856.
169. Gayle S and Burnstock G (2005) Immunolocalisation of P2X and P2Y nucleotide receptors in the rat nasal mucosa. Cell Tissue Res 319:27-36.
170. 7 nucleotide receptor activation enhances IFNγ-induced type II nitric oxide synthase activity in BV-2 microglial cells. J Neurochem 87: 344-352.
171. Gerevich Z, Borvendeg SJ, Schroder W, Franke H, Wirkner K, Norenberg W, Furst S, Gillen C, and Illes P (2004) Inhibition of N-type voltage-activated calcium channels in rat dorsal root ganglion neurons by P2Y receptors is a possible mechanism of ADP-induced analgesia. J Neurosci 24:797-807.
172. Giaroni C, Knight GE, Ruan H-Z, Glass R, Bardini M, Lecchini S, Frigo G, and Burnstock G (2002) P2 receptors in the murine gastrointestinal tract. Neuropharmacology 43:1313-1323.
173. 3 receptor localization on epidermal nerve fibers in a murine model of cancer pain. Brain Res 1044:197-205.
174. Glass R, Bardini M, Robson T, and Burnstock G (2001) Expression of nucleotide P2X receptor subtypes during spermatogenesis in the adult rat testis. Cells Tissues Org 169:377-387.
175. Göçmen C, Giesselman B, and de Groat WC (2005) Effect of neocuproine, a copper(I) chelator, on rat bladder function. J Pharmacol Exp Ther 312:1138-1143.
176. Goepfert C, Sundberg C, Sevigny J, Enjyoji K, Hoshi T, Csizmadia E, and Robson S (2001) Disordered cellular migration and angiogenesis in cd39-null mice. Circulation 104:3109-3115.
177. Gorodeski GI (2002) Regulation of transcervical permeability by two distinct P2 purinergic receptor mechanisms. Am J Physiol 282:C75-C83.
178. 2 receptor subunit. J Physiol 552:197-211.
179. Gourine AV, Dale N, Gourine VN, and Spyer KM (2004) Fever in systemic inflammation: roles of purines. Front Biosci 9:1011-1022.
180. Gourine AV, Melenchuk EV, Poputnikov DM, Gourine VN, and Spyer KM (2002) Involvement of purinergic signalling in central mechanisms of body temperature regulation in rats. Br J Pharmacol 135:2047-2055.
181. A receptors, in Chemoreception (Gonzalez G, Prabhakar JM, Pequignot JM, Nurse CA and Dalmaz Y eds) pp 375-387, Kluwer Academic/Plenum Publishers, New York.
182. Graff RD, Picher M, and Lee GM (2003) Extracellular nucleotides, cartilage stress and calcium crystal formation. Curr Opin Rheumatol 15:315-320.
183. Granstein RD, Ding W, Huang J, Holzer A, Gallo RL, Di Nardo A, and Wagner JA (2005) Augmentation of cutaneous immune responses by ATPγS: purinergic agonists define a novel class of immunologic adjuvants. J Immunol 174:7725-7731.
184. Green PG, Basbaum AI, Helms C, and Levine JD (1991) Purinergic regulation of bradykinin-induced plasma extravasation and adjuvant-induced arthritis in the rat. Proc Natl Acad Sci USA 88:4162-4165.
185. Greig AVH, James SE, McGrouther DA, Terenghi G, and Burnstock G (2003a) Purinergic receptor expression in the regenerating epidermis in a rat model of normal and delayed wound healing. Exp Dermatol 12:860-871.
186. Greig AVH, Linge C, Healy V, Lim P, Clayton E, Rustin MH, McGrouther DA, and Burnstock G (2003b) Expression of purinergic receptors in non-melanoma skin cancers and their functional roles in A431 cells. J Investig Dermatol 121:315-327.
187. Greig AVH, Linge C, Terenghi G, McGrouther DA, and Burnstock G (2003c) Purinergic receptors are part of a functional signalling system for proliferation and differentiation of human epidermal keratinocytes. J Investig Dermatol 120:1007-1015.
188. Gu JG (2003) P2X receptor-mediated modulation of sensory transmission to the spinal cord dorsal horn. Neuroscientist 9:370-378.
189. + macrophages in rat CNS during experimental autoimmune encephalomyelitis. Neuroscience 132:199-205.
190. 4 receptor by lesional activated microglia during formalin-induced inflammatory pain. J Neuroimmunol 163:120-127.
191. Gür S and Öztürk B (2000) Altered relaxant responses to adenosine and adenosine 5′-triphosphate in the corpus cavernosum from men and rats with diabetes. Pharmacology 60:105-112.
192. Hamilton SG, McMahon SB, and Lewin GR (2001) Selective activation of nociceptors by P2X receptor agonists in normal and inflamed rat skin. J Physiol (Lond) 534:437-445.
193. Han WJ, Kim SY, and Lee YB (2004) Neuroprotective effect of extracellular ATP-induced interleukin-10 expression in an in vitro model of brain ischemia, in 2004 Abstract Viewer/Itinerary Planner; Program no. 100.1. Society for Neuroscience, Washington, DC.
194. Harkema JM and Chaudry IH (1992) Magnesium-adenosine triphosphate in the treatment of shock, ischemia and sepsis. Crit Care Med 20:263-275.
195. Harvey RA, Skennerton DE, Newgreen D, and Fry CH (2002) The contractile potency of adenosine triphosphate and ecto-adenosine triphosphatase activity in guinea pig detrusor and detrusor from patients with a stable, unstable or obstructed bladder. J. Urol. 168:1235-1239.
196. Hase H, Joki N, Ishikawa H, Fukuda H, Imamura Y, Saijyo T, Tanaka Y, Takahashi Y, Inishi Y, Nakamura M, et al. (2004) Prognostic value of stress myocardial perfusion imaging using adenosine triphosphate at the beginning of haemodialysis treatment in patients with end-stage renal disease. Nephrol Dial Transplant 19:1161-1167.
197. Hashimoto M, Shinozuka K, Shahdat HM, Kwon YM, Tanabe Y, Kunitomo M, and Masumura S (1998) Antihypertensive effect of all-cis-5,8,11,14,17- icosapentaenoate of aged rats is associated with an increase in the release of ATP from the caudal artery. J Vasc Res 35:55-62.
198. Hatta Y, Aizawa S, Itoh T, Baba M, and Horie T (1994) Cytotoxic effect of extracellular ATP on L1210 leukemic cells and normal hemopoietic stem cells. Leuk Res 18:637-641.
199. Hatta Y, Takahashi M, Enomoto Y, Takahashi N, Sawada U, and Horie T (2004) Adenosine triphosphate (ATP) enhances the antitumor effect of etoposide (VP16) in lung cancer cells. Oncol Rep 12:1139-1142.
200. Hayes PD, Box H, Tull S, Bell PR, Goodall A, and Naylor AR (2003) Patients' thromboembolic potential after carotid endarterectomy is related to the platelets' sensitivity to adenosine diphosphate. J Vasc Surg 38:1226-1231.
201. Hayton MJ, Dillon JP, Glynn D, Curran JM, Gallagher JA, and Buckley KA (2005) Involvement of adenosine 5′-triphosphate in ultrasound-induced fracture repair. Ultrasound Med Biol 31:1131-1138.
202. Hegg CC, Davis K, and Lucero MT (2003a) Inhibition of heat-shock protein induction in mouse OE by in vivo administration of purinergic receptor antagonists. Chem Senses 28:A110.
203. Hegg CC, Greenwood D, Huang W, Han P, and Lucero MT (2003b) Activation of purinergic receptor subtypes modulates odor sensitivity. J Neurosci 23:8291-8301.
204. 3 receptor. Nucleic Acids Res 31:2117-2126.
205. Hervas C, Perez-Sen R, and Miras-Portugal MT (2003) Coexpression of functional P2X and P2Y nucleotide receptors in single cerebellar granule cells. J Neurosci Res 73:384-399.
206. Hetherington SL, Singh RK, Ladwick D, Thompson JR, Goodall AH, and Samani NJ (2004) Genetic regulation of the platelet adenosine diphosphate (ADP) response. Heart 90:A54.
207. Hillaire-Buys D, Bertrand G, Chapal J, Puech R, Ribes G, and Loubatières-Mariani MM (1993) Stimulation of insulin secretion and improvement of glucose tolerance in rat and dog by the P2y-purinoceptor agonist, adenosine-5′-O-(2-thiodiphosphate). Br J Pharmacol 109:183-187.
208. 7 ATP receptor modulates renal cyst development in vitro. Biochem Biophys Res Commun 322:434-439.
209. Hoebertz A, Arnett TR, and Burnstock G (2003) Regulation of bone resorption and formation by purines and pyrimidines. Trends Pharmacol Sci 24:290-297.
210. 1 receptor on bone cells. FASEB J 15:1139-1148.
211. Hollopeter G, Jantzen H-M, Vincent D, Li G, England L, Ramakrishnan V, Yang R-B, Nurden P, Nurden A, Julius D, et al. (2001) Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature (Lond) 409:202-207.
212. Holzer P (2001) Gastrointestinal afferents as targets of novel drugs for the treatment of functional bowel disorders and visceral pain. Eur J Pharmacol 429:177-193.
213. 3 receptor antagonist, blocks acetic acid-induced abdominal constriction in mice: comparison with reference analgesics. Pain 96: 99-105.
214. Höpfner M, Lemmer K, Jansen A, Hanski C, Riecken EO, Gavish M, Mann B, Buhr H, Glassmeier G, and Scherübl H (1998) Expression of functional P2-purinergic receptors in primary cultures of human colorectal carcinoma cells. Biochem Biophys Res Commun 251:811-817.
215. 6 receptors. Am J Physiol 282:H784-H792.
216. 2-receptor mRNA levels in congestive heart failure. Life Sci 65:1195-1206.
217. Housley GD (2000) Physiological effects of extracellular nucleotides in the inner ear. Clin Exp Pharmacol Physiol 27:575-580.
218. 1 adenosine receptor agonists: medicinal chemistry and therapeutic potential. Curr Pharm Des 10:2021-2039.
219. Imai M, Takigami K, Guckelberger O, Kaczmarek E, Csizmadia E, Bach FH, and Robson SC (2000) Recombinant adenoviral mediated CD39 gene transfer prolongs cardiac xenograft survival. Transplantation 70:864-870.
220. Inoue K (1998) ATP receptors for the protection of hippocampal functions. Jpn J Pharmacol 78:405-410.
221. Inoue K (2002) Microglial activation by purines and pyrimidines. Glia 40:156-163.
222. Inoue K, Tsuda M, and Koizumi K (2003) ATP induced three types of pain behaviors, including allodynia. Drug Dev Res 59:56-63.
223. 4. J Pharmacol Sci 94:112-114.
224. 4 receptors. Purinergic Signal 1:95-100.
225. Irnich D, Burgstahler R, and Grafe P (2001) P2 Nucleotide receptors in peripheral nerve trunk. Drug Dev Res 52:83-88.
226. Jackson EK (2001) P1 and P2 receptors in the renal system, in Purinergic and Pyrimidinergic Signalling II: Cardiovascular, Respiratory, Immune, Metabolic and Gastrointestinal Tract Function (Abbracchio MP and Williams M eds) pp 33-71, Springer-Verlag, Berlin.
227. Jacobson KA, Jarvis MF, and Williams M (2002) Purine and pyrimidine (P2) receptors as drug targets. J Med Chem 45:4057-4093.
228. Jahr CE and Jessell TM (1983) ATP excites a subpopulation of rat dorsal horn neurones. Nature (Lond) 304:730-733.
229. Jakobi H, Spinar H, Kuhl KD, Lotz P, and Haberland EJ (1977) Clinical and experimental use of ATP in internal ear diseases. Acta Otolaryngol 83:195-199.
230. 2+ signalling in glial cell pathology in the central nervous system. Eur J Pharmacol 447:247-260.
231. Janssens R and Boeynaems JM (2001) Effects of extracellular nucleotides and nucleosides on prostate carcinoma cells. Br J Pharmacol 132:536-546.
232. 3 homomeric and heteromeric channels to acute and chronic pain. Expert Opin Ther Targets 7:513-522.
233. 3 receptors. J Pharmacol Exp Ther 310:407-416.
234. 2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat. Proc Natl Acad Sci USA 99:17179-17184.
235. John GR, Simpson JE, Woodroofe MN, Lee SC, and Brosnan CF (2001) Extracellular nucleotides differentially regulate interleukin-1β signaling in primary human astrocytes: implications for inflammatory gene expression. J Neurosci 21:4134-4142.
236. Joles JA and Koomans HA (2004) Causes and consequences of increased sympathetic activity in renal disease. Hypertension 43:699-706.
237. Jonzon B, Nilsson J, and Fredholm BB (1985) Adenosine receptor-mediated changes in cyclic AMP production and DNA synthesis in cultured arterial smooth muscle cells. J Cell Physiol 124:451-456.
238. Julius S and Nesbitt S (1996) Sympathetic overactivity in hypertension: a moving target. Am J Hypertens 9:113S-120S.
239. Jun D and Kim K (2004) ATP-mediated necrotic volume increase (NVI) in substantia nigra pars compacta dopaminergic neuron, 2004 Abstract Viewer/Itinerary Planner; Program no. 222.18. Society for Neuroscience, Washington, DC.
240. Kääpä P, Jahnukainen T, Gronlund J, Rautanen M, Halkola L, and Valimaki I (1997) Adenosine triphosphate treatment for meconium aspiration-induced pulmonary hypertension in pigs. Acta Physiol Scand 160:283-289.
241. Kadowaki M, Yoneda S, and Takaki M (2003) Involvement of a purinergic pathway in the sympathetic regulation of motility in rat ileum. Auton Neurosci 104:10-16.
242. Kam PC and Nethery CM (2003) The thienopyridine derivatives (platelet adenosine diphosphate receptor antagonists), pharmacology and clinical developments. Anaesthesia 58:28-35.
243. Kapoor JR and Sladek CD (2000) Purinergic and adrenergic agonists synergize in stimulating vasopressin and oxytocin release. J Neurosci 20:8868-8875.
244. 2 treatment after experimental acute myocardial ischemia and reperfusion. Panminerva Med 42:11-15.
245. 7 nucleotide receptor reveals its regulatory roles in bone formation and resorption. Mol Endocrinol 17:1356-1367.
246. 2 receptor agonists as a treatment for patients with cystic fibrosis lung disease. Adv Drug Deliv Rev 54:1463-1474.
247. Kemp PA, Sugar RA, and Jackson AD (2004) Nucleotide-mediated mucin secretion from differentiated human bronchial epithelial cells. Am J Respir Cell Biol 31: 446-455.
248. Kennedy C and Leff P (1995) Painful connection for ATP. Nature (Lond) 377:385-386.
249. Khakh BS, Humphrey PP, and Henderson G (1997) ATP-gated cation channels (P2X purinoceptors) in trigeminal mesencephalic nucleus neurons of the rat. J Physiol (Lond) 498:709-715.
250. Khakh BS, Gittermann D, Cockayne DA, and Jones A (2003) ATP modulation of excitatory synapses onto interneurons. J Neurosci 23:7426-7437.
251. Kien ND, White DA, Reitan JA, and Eisele JH (1987) Cardiovascular function during controlled hypotension induced by adenosine triphosphate or sodium nitroprusside in the anesthetized dog. Anesth Analg 66:103-110.
252. 2U receptors that increase cytosolic calcium by a phospholipase C-dependent mechanism. J Neurochem 66:604-612.
253. 2 receptor. Br J Pharmacol 121:1445-1453.
254. King BF, Knowles I, Burnstock G, and Ramage A (2004) Investigation of the effects of P2 purinoceptor ligands on the micturition reflex in female urethane-anaesthetised rats. Br J Pharmacol 142:519-530.
255. King BF, Liu M, Townsend-Nicholson A, Pfister J, Padilla F, Ford APDW, Gever J, Oglesby IB, Schorge S, and Burnstock G (2005) Antagonism of ATP responses at P2X receptor subtypes by the pH indicator dye, phenol red. Br J Pharmacol 145:313-322.
256. Kirkup AJ, Brunsden M, and Grundy D (2001) Receptors and transmission in the brain-gut axis: potential for novel therapies. I. Receptors on visceral afferents. Am J Physiol 280:G787-G794.
257. Kishore BK, Isaac J, Fausther M, Tripp SR, Shi H, Gill PS, Braun N, Zimmermann H, Sévigny J, and Robson SC (2005) Expression of NTPDase1 and NTPDase2 in murine kidney: relevance to regulation of P2 receptor signaling. Am J Physiol 288:F1032-F1043.
258. Kitahara S, Yamashita M, and Ikemoto Y (2003) Effects of pentobarbital on purinergic P2X receptors of rat dorsal root ganglion neurons. Can J Physiol Pharmacol 81:1085-1091.
259. Kitchen AM, Collins HL, DiCarlo SE, Scislo TJ, and O'Leary DS (2001) Mechanisms mediating NTS P2X receptor-evoked hypotension: cardiac output vs. total peripheral resistance. Am J Physiol 281:H2198-H2203.
260. 1 receptor-mediated nitric oxide production. Neuropsychopharmacology 28:435-444.
261. 2 purinoceptors. Eur J Pharmacol 406:R13-R14.
262. Klepeis VE, Weinger I, Kaczmarek E, and Trinkaus-Randall V (2004) P2Y receptors play a critical role in epithelial cell communication and migration. J Cell Biochem 93:1115-1133.
263. Knight GE, Bodin P, de Groat WC, and Burnstock G (2002) ATP is released from guinea pig ureter epithelium on distension. Am J Physiol 282:F281-F288.
264. Knutsen LJS and Murray TF (1997) Adenosine and ATP in epilepsy, in Purinergic Approaches in Experimental Therapeutics (Jacobson KA and Jarvis MF eds) pp 423-447, Wiley-Liss, New York.
265. Ko WH, Au CL, and Yip CY (2003) Multiple purinergic receptors lead to intracellular calcium increases in cultured rat sertoli cells. Life Sci 72:1519-1535.
266. Köles L, Fürst S, and Illes P (2005) P2X and P2Y receptors as possible targets of therapeutic manipulators in CNS illnesses. Drug News Perspect 18:1-17.
267. Komarova SV, Dixon SJ, and Sims SM (2001) Osteoclast ion channels: potential targets for antiresorptive drugs. Curr Pharm Des 7:637-654.
268. 7 receptors to activate NF-B in osteoclasts. J Bone Miner Res 19:642-651.
269. 6 receptor mediates colonic NaCl secretion via differential activation of cAMP-mediated transport. J Clin Investig 111:371-379.
270. Kouakam C, Lauwerier B, Klug D, Jarwe M, Marquie C, Lacroix D, and Kacet S (2003) Effect of elevated heart rate preceding the onset of ventricular tachycardia on antitachycardia pacing effectiveness in patients with implantable cardioverter defibrillators. Am J Cardiol 92:26-32.
271. Kowaluk EA and Jarvis MF (2000) Therapeutic potential of adenosine kinase inhibitors. Expert Opin Investig Drugs 9:551-564.
272. Kucher BM and Neary JT (2005) Bi-functional effects of ATP/P2 receptor activation on tumour necrosis factor-α release in lipopolysaccharide- stimulated astrocytes. J Neurochem 92:525-535.
273. Kulkarni AA, Trousdale MD, Stevenson D, Gukasyan HJ, Shiue MH, Kim KJ, Read RW, and Lee VH (2003) Nucleotide-induced restoration of conjunctival chloride and fluid secretion in adenovirus type 5-infected pigmented rabbit eyes. J Pharmacol Exp Ther 305:1206-1211.
274. Kumahashi N, Ochi M, Kataoka H, Uchio Y, Kakimaru H, Sugawara K, and Enomoto K (2004) Involvement of ATP, increase of intracellular calcium and the early expression of c-fos in the repair of rat fetal articular cartilage. Cell Tissue Res 317:117-128.
275. Kumar V, Templeman L, Chapple CR, and Chess-Williams R (2003) Recent developments in the management of detrusor overactivity. Curr Opin Urol 13:285-291.
276. Kunapuli SP, Ding Z, Dorsam RT, Kim S, Murugappan S, and Quinton TM (2003) ADP receptors-targets for developing antithrombotic agents. Curr Pharmacol Des 9:2303-2316.
277. Kusner DJ and Barton JA (2001) ATP stimulates human macrophages to kill intracellular virulent mycobacterium tuberculosis via calcium-dependent phagosome-lysosome fusion. J Immunol 167:3308-3315.
278. Lammas DA, Stober C, Harvey CJ, Kendrick N, Panchalingam S, and Kumararatne DS (1997) ATP-induced killing of mycobacteria by human macrophages is mediated by purinergic P2Z(P2X7) receptors. Immunity 7:433-444.
279. Lara DR and Souza DO (2000) Schizophrenia: a purinergic hypothesis. Med Hypotheses 54:157-166.
280. Lecci A, Santicioli P, and Maggi CA (2002) Pharmacology of transmission to gastrointestinal muscle. Curr Opin Pharmacol 2:630-641.
281. Lee DK, Gray RD, and Lipworth BJ (2003) Adenosine monophosphate bronchial provocation and the actions of asthma therapy. Clin Exp Allergy 33:287-294.
282. Lee H, Jun DJ, Suh BC, Choi BH, Lee JH, Do MS, Suh BS, Ha H, and Kim KT (2005) Dual roles of P2 purinergic receptors in insulin-stimulated leptin production and lipolysis in differentiated rat white adipocytes. J Biol Chem 280:28556-28563.
283. Lee SC and Pappone PA (1997) Effects of P2 purinergic receptor stimulation in brown adipocytes. Am J Physiol 273:C679-C686.
284. Lee YJ and Han HJ (2005) Effect of adenosine triphosphate in renal ischemic injury: involvement of NF-κB. J Cell Physiol 204:792-799.
285. 7 receptor function in lung alveolar macrophages: pharmacologic characterization and bidirectional regulation by Th1 and Th2 cytokines. Drug Dev Res 59:118-127.
286. Lemoli RM, Ferrari D, Fogli M, Rossi L, Pizzirani C, Forchap S, Chiozzi P, Vaselli D, Bertolini F, Foutz T, et al. (2004) Extracellular nucleotides are potent stimulators of human hematopoietic stem cells in vitro and in vivo. Blood 104:1662-1670.
287. 2+)-adenosine triphosphatase activity in kidney membranes from streptozocin non-insulin-dependent diabetic rats. Metabolism 43:604-613.
288. 3 receptor subunits can account for ATP-gated currents in sensory neurons. Nature (Lond) 377:432-435.
289. Liang BT and Jacobson KA (1999) Adenosine and ischemic preconditioning. Curr Pharm Des 5:1029-1041.
290. Liang SD, Gao Y, Xu CS, Xu BH, and Mu SN (2004) Effect of tetramethylpyrazine on acute nociception mediated by signaling of P2X receptor activation in rat. Brain Res 995:247-252.
291. Liang SD, Xu CS, Zhou HQ, Liu Y, GaoY and Li GL (2005) Tetramethylpyrazine inhibits ATP-activated currents in rat dorsal root ganglion neurons. Brain Res 1040:92-97.
292. Livingston M, Heaney LG, and Ennis M (2004) Adenosine, inflammation and asthma - a review. Inflamm Res 53:171-178.
293. 2 release from human rheumatoid synovial cells. Arthritis Rheum 41:246-255.
294. Loubatières-Mariani MM, Hillaire-Buys D, Chapal J, Bertrand G, and Petit P (1997) P2 purinoceptor agonists: new insulin secretagogues potentially useful in the treatment of non-insulin-dependent diabetes mellitus, in Purinergic Approaches in Experimental Therapeutics (Jacobson KA and Jarvis MF eds) pp 253-260, Wiley-Liss, New York
295. Lu SH, Fraser MO, Chancellor MB, Cheng CL, and de Groat WC (2002) Voiding dysfunction and purinergic mechanisms in awake chronic spinal cord injured (SCI) rats, in 2004 Abstract Viewer/Itinerary Planner; Program no. 68.6. Society for Neuroscience, Washington, DC.
296. Luttikhuizen DT, Harmsen MC, de Leij LF, and van Luyn MJ (2004) Expression of P2 receptors at sites of chronic inflammation. Cell Tissue Res 317:289-298.
297. Macdonald RL (2000) Editorial comment. Stroke 31:1384-1385.
298. Machado-Vieira R, Lara DR, Souza DO, and Kapczinski F (2002) Purinergic dysfunction in mania: an integrative model. Med Hypotheses 58:297-304.
299. + absorption by extracellular nucleotides in human normal and cystic fibrosis airways. Am J Respir Cell Mol Biol 23:755-761.
300. 2 receptor agonist INS37217 stimulates RPE fluid transport in vitro and retinal reattachment in rat. Investig Ophthalmol Vis Sci 43:3555-3566.
301. + double-positive thymocytes in mice infected with Trypanosoma cruzi. Microbes Infect 5:1363-1371.
302. Mantyh PW, Clohisy DR, Koltzenburg M, and Hunt SP (2002) Molecular mechanisms of cancer pain. Nat Rev Cancer 2:201-209.
303. Marcus AJ, Broekman MJ, Drosopoulos JH, Islam N, Pinsky DJ, Sesti C, and Levi R (2003) Metabolic control of excessive extracellular nucleotide accumulation by CD39/ecto-nucleotidase-1: implications for ischemic vascular diseases. J Pharmacol Exp Ther 305:9-16.
304. Matsagas M, Jagroop IA, Geroulakos G, and Mikhailidis DP (2003) The effect of a loading dose (300 mg) of clopidogrel on platelet function in patients with peripheral arterial disease. Clin Appl Thromb Hemost 9:115-120.
305. Matsumoto N, Sorimachi M, and Akaike N (2004) Excitatory effects of ATP on rat dorsomedial hypothalamic neurons. Brain Res 1009:234-237.
306. McCallion K, Harkin DW, and Gardiner KR (2004) Role of adenosine in immunomodulation: review of the literature. Crit Care Med 32:273-277.
307. 2/3-related antinociception in rat models of inflammatory and chemogenic pain but not neuropathic pain. Br J Pharmacol 146:180-188.
308. 2/3 receptor antagonist, on neuropathic, inflammatory and chemogenic nociception following intrathecal and intraplantar administration. Br J Pharmacol 140:1381-1388.
309. McNamara N, Gallup M, Khong A, Sucher A, Maltseva I, Fahy JV, and Basbaum C (2004) Adenosine up-regulation of the mucin gene, MU2, in asthma. FASEB J 18:1770-1772.
310. Meade CJ, Dumont I, and Worrall L (2001) Why do asthmatic subjects respond so strongly to inhaled adenosine? Life Sci 69:1225-1240.
311. Meme W, Ezan P, Venance L, Glowinski J, and Giaume C (2004) ATP-induced inhibition of gap junctional communication is enhanced by interleukin-1β treatment in cultured astrocytes. Neuroscience 126:95-104.
312. Mietz H, Chevez-Barrios P, Feldman RM, and Lieberman MW (1998) Suramin inhibits wound healing following filtering procedures for glaucoma. Br J Ophthalmol 82:816-820.
313. Mizumoto N, Mummert ME, Shalhevet D, and Takashima A (2003) Keratinocyte ATP release assay for testing skin-irritating potentials of structurally diverse chemicals. J Investig Dermatol 121:1066-1072.
314. Mizuno K, Okamoto H, and Horio T (2004) Inhibitory influences of xanthine oxidase inhibitor and angiotensin I-converting enzyme inhibitor on multinucleated giant cell formation from monocytes by downregulation of adhesion molecules and purinergic receptors. Br J Dermatol 150:205-210.
315. Mockett BG, Housley GD, and Thorne PR (1994) Fluorescence imaging of extracellular purinergic receptor sites and putative ecto-ATPase sites on isolated cochlear hair cells. J Neurosci 14:6992-7007.
316. Morciano M, Ortinau S, and Zimmermann H (2004) Guanine nucleotides inhibit NMDA and kainate-induced neurotoxicity in cultured rat hippocampal and neocortical neurons. Neurochem Int 45:95-101.
317. Moreland RB, Brioni JD, and Sullivan JP (2004) Emerging pharmacologic approaches for the treatment of lower urinary tract disorders. J Pharmacol Exp Ther 308:797-804.
318. Mori M, Heuss C, Gahwiler BH, and Gerber U (2001) Fast synaptic transmission mediated by P2X receptors in CA3 pyramidal cells of rat hippocampal slice cultures. J Physiol (Lond) 535:115-123.
319. Mori M, Tsushima H, and Matsuda T (1994) Antidiuretic effects of ATP induced by microinjection into the hypothalamic supraoptic nucleus in water-loaded and ethanol-anesthetized rats. Jpn J Pharmacol 66:445-450.
320. 2 metabotropic receptors in ATP-induced transient receptor potential vanilloid receptor 1-mediated thermal hypersensitivity. J Neurosci 23:6058-6062.
321. Mork H, Ashina M, Bendtsen L, Olesen J, and Jensen R (2003) Experimental muscle pain and tenderness following infusion of endogenous substances in humans. Eur J Pain 7:145-153.
322. Mukai C and Okuno M (2004) Glycolysis plays a major role for adenosine triphosphate supplementation in mouse sperm flagellar movement. Biol Reprod 71:540-547.
323. Mulligan SJ and MacVicar BA (2004) Calcium transients in astrocyte endfeet cause cerebrovascular constrictions. Nature (Lond) 431:195-199.
324. Munoz DJ, Kendrick IS, Rassam M, and Thorne PR (2001) Vesicular storage of adenosine triphosphate in the guinea-pig cochlear lateral wall and concentrations of ATP in the endolymph during sound exposure and hypoxia. Acta Otolaryngol 121:10-15.
325. Murakami K, Nakamura Y, and Yoneda Y (2003) Potentiation by ATP of lipopolysaccharide-stimulated nitric oxide production in cultured astrocytes. Neuroscience 117:37-42.
326. 2 receptor stimulation increases tear fluid secretion in rabbits. Curr Eye Res 21:782-787.
327. 2+-ATPase expression and ATP content in lenses of hereditary cataract UPL rats. Toxicology 197:177-183.
328. Naemsch LN, Du X, Sims SM, and Dixon SJ (2001) P2 nucleotide receptors in osteoclasts. Drug Dev Res 53:130-139.
329. 2+ response in mouse mammary myoepithelial cells. Pflueg Arch Eur J Physiol 442:57-63.
330. Nalos M, Asfar P, Ichai C, Radermacher P, Leverve XM, and Froba G (2003) Adenosine triphosphate-magnesium chloride: relevance for intensive care. Intensive Care Med 29:10-18.
331. Nathanson MH, Burgstahler AD, Masyuk A, and LaRusso NF (2001) Stimulation of ATP secretion in the liver by therapeutic bile acids. Biochem J 358:1-5.
332. Naus CC, Ozog MA, Bechberger JF, and Nakase T (2001) A neuroprotective role for gap junctions. Cell Commun Adhes 8:325-328.
333. Neary JT, Kang Y, and Shi YF (2004) Signaling from nucleotide receptors to protein kinase cascades in astrocytes. Neurochem Res 29:2037-2042.
334. Neary JT, Kang Y, Tran M, and Feld J (2005) Traumatic injury activates protein kinase B/Akt in cultured astrocytes: role of extracellular ATP and P2 purinergic receptors. J Neurotrauma 22:491-500.
335. Neary JT, Kang Y, Willoughby KA, and Ellis EF (2003) Activation of extracellular signal-regulated kinase by stretch-induced injury in astrocytes involves extracellular ATP and P2 purinergic receptors. J Neurosci 23:2348-2356.
336. Neary JT, McCarthy M, Cornell-Bell A, and Kang Y (1999) Trophic signaling pathways activated by purinergic receptors in rat and human astroglia. Prog Brain Res 120:323-332.
337. Needleman P, Minkes MS, and Douglas JR (1974) Stimulation of prostaglandin biosynthesis by adenine nucleotides. Profile of prostaglandin release by perfused organs. Circ Res 34:455-460.
338. Neuhuber WL and Tiegs G (2004) Innervation of immune cells: evidence for neuroimmunomodulation in the liver. Anat Rec 280A:884-892.
339. Newman EA (2003) Glial cell inhibition of neurons by release of ATP. J Neurosci 23:1659-1666.
340. Nishiguchi J, Sasaki K, Seki S, Chancellor MB, Erickson KA, de Groat WC, Kumon H, and Yoshimura N (2004) Effects of isolectin B4-conjugated saporin, a targeting cytotoxin, on bladder overactivity induced by bladder irritation. Eur J Neurosci 20:474-482.
341. Nishiyama A and Navar LG (2002) ATP mediates tubuloglomerular feedback. Am J Physiol 283:R273-R275.
342. 3 receptors and peripheral pain mechanisms. J Physiol (Lond) 554:301-308.
343. 12/thrombin in ADP- and thrombin-induced human platelet activation. Br J Pharmacol 142:1325-1331.
344. 2 purinoceptors in MCG 101 murine sarcoma cells and HT-29 human colon carcinoma cells. Auton Neurosci 112:69-79.
345. Ogata T, Chuai M, Morino T, Yamamoto H, Nakamura Y, and Schubert P (2003) Adenosine triphosphate inhibits cytokine release from lipopolysaccharide- activated microglia via P2Y receptors. Brain Res 981:174-183.
346. Okada M, Nakagawa T, Minami M, and Satoh M (2002) Analgesic effects of intrathecal administration of P2Y nucleotide receptor agonists UTP and UDP in normal and neuropathic pain model rats. J Pharmacol Exp Ther 303:66-73.
347. 2A adenosine receptor: a novel therapeutic target in renal disease. Am J Physiol 282:F10-F18.
348. 2+ concentration in ATP-stimulated rat brown adipocytes. Exp Physiol 87:643-652.
349. O'Reilly BA, Kosaka AH, Knight GE, Chang TK, Ford APDW, Rymer JM, Popert R, Burnstock G, and McMahon SB (2002) P2X receptors and their role in female idiopathic detrusor instability. J Urol 167:157-164.
350. Ouslander JG (2004) Management of overactive bladder. N Engl J Med 350:786-799.
351. Pankratov YV, Lalo UV, and Krishtal OA (2002) Role for P2X receptors in long-term potentiation. J Neurosci 22:8363-8369.
352. Papka RE, Hafemeister J, and Storey-Workley M (2005) P2X receptors in the rat uterine cervix, lumbosacral dorsal root ganglia and spinal cord during pregnancy. Cell Tissue Res 321:35-44.
353. 7 mediates superoxide production in primary microglia and is up-regulated in a transgenic mouse model of Alzheimer's disease. J Biol Chem 278:13309-13317.
354. Pascual O and Haydon PG (2003) Synaptic inhibition mediated by glia. Neuron 40:873-875.
355. Pelleg A, Pennock RS, and Kutalek SP (2002). Proarrhythmic effects of adenosine: one decade of clinical data. Am J Ther 9:141-147.
356. Peroutka SJ (2004) Migraine: a chronic sympathetic nervous system disorder. Headache 44:53-64.
357. Pintor J (2000) Purinergic signalling in the eye. in Nervous Control of the Eye (Burnstock G and Sillito A eds) pp 171-210, Harwood Academic Publishers, London.
358. Pintor J, Bautista A, Carracedo G, and Peral A (2004) UTP and diadenosine tetraphosphate accelerate wound healing in the rabbit cornea. Ophthalmic Physiol Opt 24:186-193.
359. Pintor J and Peral A (2001) Therapeutic potential of nucleotides in the eye. Drug Dev Res 52:190-195.
360. Pintor J, Peral A, Pelaez T, Carracedo G, Bautista A, and Hoyle CH (2003a) Nucleotides and dinucleotides in ocular physiology: new possibilities of nucleotides as therapeutic agents in the eye. Drug Dev Res 59:136-145.
361. Pintor J, Peral A, Pelaez T, Martin S, and Hoyle CH (2003b) Presence of diadenosine polyphosphates in the aqueous humor: their effect on intraocular pressure. J Pharmacol Exp Ther 304:342-348.
362. Pochmann D, Rücker B, Battastini AMO, and Sarkis JJF (2004) Ovariectomy and estrodiol replacement therapy alters the adenine nucleotide hydrolysis in rat blood serum. Thromb Res 114:275-281.
363. Polosa R, Rorke S, and Holgate ST (2002) Evolving concepts on the value of adenosine hyperresponsiveness in asthma and chronic obstructive pulmonary disease. Thorax 57:649-654.
364. 3 purine receptor subunits in the guinea pig enteric nervous system. Auton Neurosci 101:39-47.
365. Premkumar LS (2001) Interaction between vanilloid receptors and purinergic metabotropic receptors: pain perception and beyond. Proc Natl Acad Sci USA 98:6537-6539.
366. Punj V, Zaborina O, Dhiman N, Falzari K, Bagdasarian M, and Chakrabarty AM (2000) Phagocytic cell killing mediated by secreted cytotoxic factors of Vibrio cholerae. Infect Immun 68:4930-4937.
367. Ralevic V and Burnstock G (1998) Receptors for purines and pyrimidines. Pharmacol Rev 50:413-492.
368. Ralevic V and Burnstock G (2003) Involvement of purinergic signalling in cardiovascular diseases. Drug News Perspect 16:133-140.
369. Rapaport E (1983) Treatment of human tumor cells with ADP or ATP yields arrest of growth in the S phase of the cell cycle. J Cell Physiol 114:279-283.
370. Rapp DE, Lyon MB, Bales GT, and Cook SP (2005) A role for the P2X receptor in urinary tract physiology and in the pathophysiology of urinary dysfunction. Eur Urol 48:303-308.
371. Rathbone MP, Middlemiss PJ, Gysbers JW, Andrew C, Herman MA, Reed JK, Ciccarelli R, Di Iorio P, and Caciagli F (1999) Trophic effects of purines in neurons and glial cells. Prog Neurobiol 59:663-690.
372. Ray FR, Huang W, Slater M, and Barden JA (2002) Purinergic receptor distribution in endothelial cells in blood vessels: a basis for selection of coronary artery grafts. Atherosclerosis 162:55-61.
373. Rees DA, Scanlon MF, and Ham J (2003) Novel insights into how purines regulate pituitary cell function. Clin Sci (Lond) 104:467-481.
374. Regnier M, Rivera AJ, Chen Y, and Chase PB (2000) 2-Deoxy-ATP enhances contractility of rat cardiac muscle. Circ Res 86:1211-1217.
375. 3 in painful and nonpainful human tooth pulp. J Orofac Pain 17:245-250.
376. Ribeiro JA, Sebastião AM, and de Mendonça A (2003) Adenosine receptors in the nervous system: pathophysiological implications. Prog Neurobiol 68:377-392.
377. Rich PB, Douillet CD, Mahler SA, Husain SA, and Boucher RC (2003) Adenosine triphosphate is released during injurious mechanical ventilation and contributes to lung edema. J Trauma 55:290-297.
378. 4 purinergic receptor protein expression is upregulated in placenta from preeclamptic pregnancies. J Soc Gynecol Investig 12:P363A.
379. Robson SC, Enjyoji K, Goepfert C, Imai M, Kaczmarek E, Lin Y, Sevigny J, and Warny M (2001) Modulation of extracellular nucleotide-mediated signaling by CD39/nucleoside triphosphate diphosphohydrolase-1. Drug Dev Res 53:193-207.
380. Rocha I, Burnstock G, and Spyer KM (2001) Effect on urinary bladder function and arterial blood pressure of the activation of putative purine receptors in brainstem areas. Auton Neurosci 88:6-15.
381. Rong W and Burnstock G (2004) Activation of ureter nociceptors by exogenous and endogenous ATP in guinea pig. Neuropharmacology 47:1093-1101.
382. Rong W, Burnstock G, and Spyer KM (2000) P2X purinoceptor-mediated excitation of trigeminal lingual nerve terminals in an in vitro intra-arterially perfused rat tongue preparation. J Physiol (Lond) 524:891-902.
383. Rong W, Spyer M, and Burnstock G (2002) Activation and sensitisation of low and high threshold afferent fibres mediated by P2X receptors in the mouse urinary bladder. J Physiol (Lond) 541:591-600.
384. Rossato M, La Sala GB, Balasini M, Taricco F, Galeazzi C, Ferlin A, and Foresta C (1999) Sperm treatment with extracellular ATP increases fertilization rates in in-vitro fertilization for male factor infertility. Hum Reprod 14:694-697.
385. Rost S, Daniel C, Schulze-Lohoff E, Baumert HG, Lambrecht G, and Hugo C (2002) P2 receptor antagonist PPADS inhibits mesangial cell proliferation in experimental mesangial proliferative glomerulonephritis. Kidney Int 62:1659-1671.
386. 4 receptors in dorsal root, nodose and trigeminal ganglia of the rat. Histochem Cell Biol 120:415-426.
387. Ryan LM, Rachow JW, and McCarty DJ (1991) Synovial fluid ATP: a potential substrate for the production of inorganic pyrophosphate. J Rheumatol 18:716-720.
388. Ryten M, Yang SY, Dunn PM, Goldspink G, and Burnstock G (2004) Purinoceptor expression in regenerating skeletal muscle in the mdx mouse model of muscular dystrophy and in satellite cell cultures. FASEB J 18:1404-1406.
389. Saini HK, Shao Q, Musat S, Takeda N, Tappia PS, and Dhalla NS (2005) Imidapril treatment improves the attenuated inotropic and intracellular calcium responses to ATP in heart failure due to myocardial infarction. Br J Pharmacol 144:202-211.
390. Sanz JM and Di Virgilio F (2000) Kinetics and mechanism of ATP-dependent IL-1β release from microglial cells. J Immunol 164:4893-4898.
391. 7 receptor abolishes ATP-mediated killing of mycobacteria. J Immunol 171:5442-5446.
392. Sawynok J and Liu XJ (2003) Adenosine in the spinal cord and periphery: release and regulation of pain. Prog Neurobiol 69:313-340.
393. Schmidt M and Loffler G (1998) Induction of aromatase activity in human adipose tissue stromal cells by extracellular nucleotides - evidence for P2-purinoceptors in adipose tissue. Eur J Biochem 252:147-154.
394. 11 receptor signaling. Blood 102: 613-620.
395. Schodel J, Weise I, Klinger R, and SchmidtM(2004) Stimulation of lipogenesis in rat adipocytes by ATP, a ligand for P2-receptors. Biochem Biophys Res Commun 321:767-773.
396. Schofl C, Rossig L, Potter E, von zur Muhlen A and Brabant G (1995) Extracellular ATP and UTP increase cytosolic free calcium by activating a common P2u-receptor in single human thyrocytes. Biochem Biophys Res Commun 213:928-934.
397. Schulman ES, Glaum MC, Post T, Wang Y, Raible DG, Mohanty J, Butterfield JH, and Pelleg A (1999) ATP modulates anti-IgE-induced release of histamine from human lung mast cells. Am J Respir Cell Mol Biol 20:530-537.
398. Schwiebert EM (2003) Cellular mechanisms and physiology of nucleotide and nucleoside release from cells: current knowledge, novel assays to detect purinergic agonists, and future directions. Curr Top Membr 54:31-58.
399. Schwiebert EM, Wallace DP, Braunstein GM, King SR, Peti-Peterdi J, Hanaoka K, Guggino WB, Guay-Woodford LM, Bell PD, Sullivan LP, et al. (2002) Autocrine extracellular purinergic signaling in epithelial cells derived from polycystic kidneys. Am J Physiol 282:F763-F775.
400. Scislo TJ, Kitchen AM, Augustyniak RA, and O'Leary DS (2001) Differential patterns of sympathetic responses to selective stimulation of nucleus tractus solitarius purinergic receptor subtypes. Clin Exp Pharmacol Physiol 28:120-124.
401. Selzner N, Selzner M, Graf R, Ungethuem U, Fitz JG, and Clavien P-A (2004) Water induces autocrine stimulation of tumour cell killing through ATP release and P2 receptor binding. Cell Death Differ 11:S172-S180.
402. Sesti C, Broekman MJ, Drosopoulos JH, Islam N, Marcus AJ, and Levi R (2002) Ectonucleotidase in cardiac sympathetic nerve endings modulates ATP-mediated feedback of norepinephrine release. J Pharmacol Exp Ther 300:605-611.
403. Sevigny J, Sundberg C, Braun N, Guckelberger O, Csizmadia E, Qawi I, Imai M, Zimmermann H, and Robson SC (2002) Differential catalytic properties and vascular topography of murine nucleoside triphosphate diphosphohydrolase 1 (NTP-Dase1) and NTPDase2 have implications for thromboregulation. Blood 99:2801-2809.
404. 2 nucleotide receptor mediates UTP-induced vascular cell adhesion molecule-1 expression in coronary artery endothelial cells. J Biol Chem 278:24960-24965.
405. Shabbir M, Thompson CS, Mikhailidis DP, Morgan RJ, and Burnstock G (2003) Extracellular ATP attenuates the growth of hormone refractory prostate cancer in vivo, in 5th World Congress of Urological Research; 2003 Sep 24-27; Kensington, London, UK.
406. Shabbir M, Thompson CS, Mikhailidis DP, Morgan RJ, and Burnstock G (2004) Adenosine 5′-triphosphate (ATP) increases the cytotoxic effect of mitomycin C in the treatment of high-grade bladder cancer. J Urol 171 (Suppl 4):260.
407. Shields CB, Zhang YP, Chen S, Han Y, Shields LBE, Chiang B, Burke DA, and Haskins R (2004) Treatment of spinal cord injury via topical perfusion with an ATP solution, in 2004 Abstract Viewer/Itinerary Planner; Program no. 418.8. Society for Neuroscience, Washington, DC.. Program no. 418.8.
408. 3 receptor expression in the trigeminal ganglion following monoarthritis of the temporomandibular joint in rats. Pain 116:42-51.
409. Shirley DG, Bailey MA, and Unwin RJ (2005) In vivo stimulation of apical P2 receptors in collecting ducts: evidence for inhibition of sodium reabsorption. Am J Physiol 288:F1243-F1248.
410. 7-independent mechanism. J Immunol 163:558-561.
411. Silinsky EM, Gerzanich V, and Vanner SM (1992) ATP mediates excitatory synaptic transmission in mammalian neurones. Br J Pharmacol 106:762-763.
412. Simola N, Fenu S, Baraldi PG, Tabrizi MA, and Morelli M (2004) Blockade of adenosine A2A receptors antagonizes parkinsonian tremor in the rat tacrine model by an action on specific striatal regions. Exp Neurol 189:182-188.
413. Sinoway LI and Li J (2005) A perspective on the muscle reflex: implications for congestive heart failure. J Appl Physiol 99:5-22.
414. Sissons J, Alsam S, Jayasekera S, and Khan NA (2004) Ecto-ATPases of clinical and non-clinical isolates of Acanthamoeba. Microb Pathog 37:231-239.
415. Smith CP, Radziszewski P, Borkowski A, Somogyi GT, Boone TB, and Chancellor MB (2004) Botulinum toxin A has antinociceptive effects in treating interstitial cystitis. Urology 64:871-875.
416. Smitham JE and Barrett KE (2001) Differential effects of apical and basolateral uridine triphosphate on intestinal epithelial chloride secretion. Am J Physiol 280:C1431-C1439.
417. Solini A, Chiozzi P, Morelli A, Passaro A, Fellin R, and Di Virgilio F (2003) Defective P2Y purinergic receptor function: a possible novel mechanism for impaired glucose transport. J Cell Physiol 197:435-444.
418. Solini A, Iacobini C, Ricci C, Chiozzi P, Amadio L, Pricci F, Di Mario U, Di Virgilio F, and Pugliese G (2005) Purinergic modulation of mesangial extracellular matrix production: role in diabetic and other glomerular diseases. Kidney Int 67:875-885.
419. 6 purinergic receptor in human T cells infiltrating inflammatory bowel disease. Lab Investig 78:1375-1383.
420. Sommer JA, Fisette PL, Hu Y, Denlinger LC, Guerra AN, Bertics PJ, and Proctor RA (1999) Purinergic receptor modulation of LPS-stimulated signaling events and nitric oxide release in RAW 264.7 macrophages. J Endotoxin Res 5:70-74.
421. Sommerschild HT and Kirkeboen KA (2000) Adenosine and cardioprotection during ischaemia and reperfusion-an overview. Acta Anaesthesiol Scand 44:1038-1055.
422. Sone H, Sasaki Y, Komai M, Toyomizu M, Kagawa Y, and Furukawa Y (2004) Biotin enhances ATP synthesis in pancreatic islets of the rat, resulting in reinforcement of glucose-induced insulin secretion. Biochem Biophys Res Commun 314:824-829.
423. Sorkin LS, Maruyama K, Boyle DL, Yang L, Marsala M, and Firestein GS (2003) Spinal adenosine agonist reduces c-fos and astrocyte activation in dorsal horn of rats with adjuvant-induced arthritis. Neurosci Lett 340:119-122.
424. Soto D, Pintor J, Peral A, Gual A, and Gasull X (2005) Effects of dinucleoside polyphosphates on trabecular meshwork cells and aqueous humor outflow facility. J Pharmacol Exp Ther 314:1042-1051.
425. 2/3 heteromeric receptors. Br J Pharmacol 135:1524-1530.
426. Sperlágh B, Mergl Z, Jurányi Z, Vizi ES, and Makara GB (1999) Local regulation of vasopressin and oxytocin secretion by extracellular ATP in the isolated posterior lobe of the rat hypophysis. J Endocrinol 160:343-350.
427. Sprague RS, Ellsworth ML, and Detrich HH (2003) Nucleotide release and purinergic signaling in the vasculature driven by the red blood cell. Curr Top Membr 54:243-268.
428. Sprague RS, Stephenson AH, Ellsworth ML, Keller C, and Lonigro AJ (2001) Impaired release of ATP from red blood cells of humans with primary pulmonary hypertension. Exp Biol Med (Maywood) 226:434-439.
429. Stevens B, Porta S, Haak LL, Gallo V, and Fields RD (2002) Adenosine: a neuronglial transmitter promoting myelination in the CNS in response to action potentials. Neuron 36:855-868.
430. Stober CB, Lammas DA, Li CM, Kumararatne DS, Lightman SL, and McArdle CA (2001) ATP-Mediated killing of Mycobacterium bovis bacille Calmette- Guérin within human macrophages is calcium dependent and associated with the acidification of mycobacteria-containing phagosomes. J Immunol 166:6276-6286.
431. 2 receptor-channels and their role in calcium signaling in pituitary cells. Biochem Cell Biol 78:393-404.
432. Stone LS and Vulchanova L (2003) The pain of antisense: in vivo application of antisense oligonucleotides for functional genomics in pain and analgesia. Adv Drug Deliv Rev 55:1081-1112.
433. Stutts MJ and Boucher RC (1999) Cystic fibrosis gene and functions of CFTR implications of dysfunctional ion transport for pulmonary pathogenesis, in Cystic Fibrosis in Adults (Yankaskas JR and Knowles MR eds) pp 3-25, Lippincott-Raven, Philadelphia.
434. Sueta T, Paki B, Everett AW, and Robertson D (2003) Purinergic receptors in auditory neurotransmission. Hear Res 183:97-108.
435. Sugahara K, Shimogori H, Okuda T, Takemoto T, Hashimoto M, and Yamashita H (2004) Cochlear administration of adenosine triphosphate facilitates recovery from acoustic trauma (temporary threshold shift). ORL J Otorhinolaryngol Relat Spec 66:80-84.
436. 7-induced pore formation and apoptosis: an early effect of diabetes on the retinal microvasculature. Investig Ophthalmol Vis Sci 45:1026-1032.
437. 2 reduces cyclosporine nephrotoxicity. Surgery 101:315-322.
438. 2. 1. Effects on the cis- diamminedichloroplatinum-treated isolated perfused kidneys. J Surg Res 38:429-437.
439. 2 after warm ischemia. Am J Physiol 247:R1047-R1053.
440. Sun Y and Chai TC (2002) Effects of dimethyl sulphoxide and heparin on stretch-activated ATP release by bladder urothelial cells from patients with interstitial cystitis. BJU Int 90:381-385.
441. Szalay KS, Orso E, Juranyi Z, Vinson GP, and Vizi ES (1998) Local non-synaptic modulation of aldosterone production by catecholamines and ATP in rat: implications for a direct neuronal fine tuning. Horm Metab Res 30:323-328.
442. Szentpali K, Kaszaki J, Tiszlavicz L, Lazar G, Balogh A, and Boros M (2001) Bile-induced adenosine triphosphate depletion and mucosal damage during reflux esophagitis. Scand J Gastroenterol 36:459-466.
443. Tai CJ, Kang SK, Choi KC, Tzeng CR, and Leung PC (2001) Antigonadotropic action of adenosine triphosphate in human granulosa-luteal cells: involvement of protein kinase Cα. J Clin Endocrinol Metab 86:3237-3242.
444. Tan B-H, Shimizu H, Furukawa Y, Kanemori T, and Ohyanagi M (2004) Sinus slowing caused by adenosine-5′-triphosphate in patients with and without sick sinus syndrome under various autonomic states. J Endocrinol 37:305-309.
445. Taylor AL, Schwiebert LM, Smith JJ, King C, Jones JR, Sorscher EJ, and Schwiebert EM (1999) Epithelial P2X purinergic receptor channel expression and function. J Clin Investig 104:875-884.
446. 3 receptor expression in human bladder urothelium and changes in interstitial cystitis. BJU Int 93:1344-1348.
447. Thevananther S, Sun H, Li D, Arjunan V, Awad SS, Wyllie S, Zimmerman TL, Goss JA, and Karpen SJ (2004) Extracellular ATP activates C-jun N-terminal kinase signaling and cell cycle progression in hepatocytes. Hepatology 39:393-402.
448. 1 purinergic receptors in myocardial ischemia sensory transduction. Cardiovasc Res 53:888-901.
449. Tsai S-J (2005) Adenosine A2a receptor/dopamine D2 receptor hetero-oligomerization: a hypothesis that may explain behavioural sensitization to psychostimulants and schizophrenia. Med Hypotheses 64:197-200.
450. Tsuda M, Inoue K, and Salter MW (2005) Neuropathic pain and spinal microglia: a big problem from molecules in "small" glia. Trends Neurosci 28:101-107.
451. Tsuda M, Koizumi S, and Inoue K (2001) Role of endogenous ATP at the incision area in a rat model of postoperative pain. Neuroreport 12:1701-1704.
452. 2/3 receptor signaling in capsaicin-insensitive primary afferent neurons. J Neurosci 20:RC90.
453. 4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature (Lond) 424:778-783.
454. Tsuzaki M, Bynum D, Almekinders L, Yang X, Faber J, and Banes AJ (2003) ATP modulates load-inducible IL-1β, COX 2 and MMP-3 gene expression in human tendon cells. J Cell Biochem 89:556-562.
455. Turner C, Ramesh B, Srai SKS, Burnstock G, and Unwin R (2004a) Altered P2 receptor expression in the Han:SPRD cy/+ rat, a model of autosomal dominant polycystic kidney disease. Cell Tissues Organs 178:168-179.
456. 7 receptor is increased in proliferative glomerulonephritis (Abstract). Society of Nephrology, Renal Week; 2004 Oct 27-Nov 1; St. Louis, MO.
457. Turner JT, Landon LA, Gibbons SJ, and Talamo BR (1999) Salivary gland P2 nucleotide receptors. Crit Rev Oral Biol Med 10:210-224.
458. Ueda H and Rashid MH (2003) Molecular mechanism of neuropathic pain. Drug News Perspect 16:605-613.
459. Uhlmann S, Bringmann A, Uckermann O, Pannicke T, Weick M, Ulbricht E, Goczalik I, Reichenbach A, Wiedemann P, and Francke M (2003) Early glial cell reactivity in experimental retinal detachment: effect of suramin. Investig Ophthalmol Vis Sci 44:4114-4122.
460. Undem BJ, Chuaychoo B, Lee MG, Weinreich D, Myers AC, and Kollarik M (2004) Subtypes of vagal afferent C-fibres in guinea-pig lungs. J Physiol 556:905-917.
461. Unwin RJ, Bailey MA, and Burnstock G (2003) Purinergic signaling along the renal tubule: the current state of play. News Physiol Sci 18:237-241.
462. 3 receptors in the guinea-pig ileum. Histochem Cell Biol 118:193-203.
463. 7, an ionotropic purinergic receptor, in rat gastrointestinal musculature. Cell Tissue Res 312:149-154.
464. Vanoverberghe K, Mariot P, Vanden AF, Delcourt P, Parys JB, and Prevarskaya N (2003) Mechanisms of ATP-induced calcium signaling and growth arrest in human prostate cancer cells. Cell Calcium 34:75-85.
465. Vassort G (2001) Adenosine 5′-triphosphate: a P2-purinergic agonist in the myocardium. Physiol Rev 81:767-806.
466. Vianna EP, Ferreira AT, Naffah-Mazzacoratti MG, Sanabria ER, Funke M, Cavalheiro EA and Fernandes MJ (2002) Evidence that ATP participates in the pathophysiology of pilocarpine-induced temporal lobe epilepsy: fluorimetric, immunohistochemical and western blot studies. Epilepsia 43 (Suppl 5):227-229.
467. Vinade ER, Schmidt AP, Frizzo ME, Izquierdo I, Elisabetsky E, and Souza DO (2003) Chronically administered guanosine is anticonvulsant, amnesic and anxiolytic in mice. Brain Res 977:97-102.
468. 2/3 receptors. Mol Pharmacol 53:969-973.
469. 3 knockout mice reveal a major sensory role for urothelially released ATP. J Neurosci 21:5670-5677.
470. Volonte C, Amadio S, Cavaliere F, D'Ambrosi N, Vacca F, and Bernardi G (2003) Extracellular ATP and neurodegeneration. Curr Drug Targets CNS Neurol Disord 2:403-412.
471. Volonte C, Ciotti MT, D'Ambrosi N, Lockhart B, and Spedding M (1999) Neuroprotective effects of modulators of P2 receptors in primary culture of CNS neurones. Neuropharmacology 38:1335-1342.
472. 7 receptor in diabetic and hypertensive rat models. Kidney Int 66:157-166.
473. Vorhoff T, Zimmermann H, Pelletier J, Sévigny J, and Braun N (2005) Cloning and characterization of the ecto-nucleotidase NTPDase3 from rat brain: predicted secondary structure and relation to other members of the E-NTPDase family and actin. Purinergic Signalling 1:259-270.
474. Vulchanova L, Olson TH, Stone LS, Riedl MS, Elde R, and Honda CN (2001) Cytotoxic targeting of isolectin IB4-binding sensory neurons. Neuroscience 108:143-155.
475. Waeber C and Moskowitz MA (2003) Therapeutic implications of central and peripheral neurologic mechanisms in migraine. Neurology 61:S9-S20.
476. Wallace DJ (1989) The use of quinacrine (atabrine) in rheumatic diseases: a reexamination. Semin Arthritis Rheum 18:282-296.
477. Wammack R, Weihe E, Dienes HP, and Hohenfeller R (1995) Die neurogene blase in vitro. Akt Urol 26:16-18.
478. --dependent mechanism. Glia 37:8-18.
479. 2 receptor subunit of ATP-gated ion channels in the rat cochlea. Neuroreport 14:817-823.
480. Wang L, Andersson M, Karlsson L, Watson MA, Cousens DJ, Jern S, and Erlinge D (2003b) Increased mitogenic and decreased contractile P2 receptors in smooth muscle cells by shear stress in human vessels with intact endothelium. Arterioscler Thromb Vasc Biol 23:1370-1376.
481. Wang L, Yao H, Yang Y-E, Song I, and Owyang C (2004a) Enhanced purinergic pathway occurs in postoperative ileus: reversal by orphanin FQ. Gastroenterology 126:75.
482. Wang Q, Li X, Wang L, Febg Y-H, Zeng R, and Gorodeski G (2004b) Antiapoptotic effects of estrogen in normal and cancer human cervical epithelial cells. Endocrinology 145:5568-5579.
483. Watanabe S, Kono Y, Oishi-Tobinaga Y, Yamada S, Hara M, and Kano T (2002) A Comparison of the chronotropic and dromotropic actions between adenosine triphosphate and edrophonium in patients undergoing coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 16:598-602.
484. Watanabe S, Yoshimi Y, and Ikekita M (2003) Neuroprotective effect of adenine on Purkinje cell survival in rat cerebellar primary cultures. J Neurosci Res 74:754-759.
485. White N, Ryten M, Clayton E, Butler P, and Burnstock G (2005a) 2Y purinergic receptors regulate the growth of human melanomas. Cancer Lett 224:81-91.
486. 7 receptors. Cell Tissue Res 321:411-418.
487. Wiley LA, Rupp GR, and Steinle JJ (2005) Sympathetic innervation regulates basement membrane thickening and pericytes number in rat retina. Investig Ophthalmol Vis Sci 46:744-748.
488. Wirkner K, Koles L, Furst S, and Illes P (2003) Modulation of voltage- and ligand-gated ion channels by neuronal P2Y receptors. Drug Dev Res 59:49-55.
489. 7 receptors control 2-arachidonoylglycerol production by microglial cells. Proc Natl Acad Sci USA 101:3214-3219.
490. Wu Y, Willcockson HH, Maixner W, and Light AR (2004) Suramin inhibits spinal cord microglia activation and long-term hyperalgesia induced by formalin injection. J Pain 5:48-55.
491. Wyndaele JJ and De Wachter S (2003) The basics behind bladder pain: a review of data on lower urinary tract sensations. Int J Urol 10 (Suppl):S49-S55.
492. Wynn G, Bei M, Ruan H-Z, and Burnstock G (2004) Purinergic component of mechanosensory transduction is increased in a rat model of colitis. Am J Physiol 287:G647-G657.
493. Wynn G, Rong W, Xiang Z, and Burnstock G (2003) Purinergic mechanisms contribute to mechanosensory transduction in the rat colorectum. Gastroenterology 125: 1398-1409.
494. Xiang Z, Bo X, and Burnstock G (1999) P2X receptor immunoreactivity in the rat cochlea, vestibular ganglion and cochlear nucleus. Hear Res 128:190-196.
495. 3 receptors in the myenteric plexus of rat stomach. Histochem Cell Biol 122:111-119.
496. 3 purinoceptors in the rat enteric nervous system. Histochem Cell Biol 121:169-179.
497. Xiao HS, Huang QH, Zhang FX, Bao L, Lu YJ, Guo C, Yang L, Huang WJ, Fu G, Xu SH, et al. (2002) Identification of gene expression profile of dorsal root ganglion in the rat peripheral axotomy model of neuropathic pain. Proc Natl Acad Sci USA 99:8360-8365.
498. 2 production in astrocytes: regulation by cytokines, extracellular ATP and oxidative agents. Prostaglandins Leukot Essent Fatty Acids 69:437-448.
499. 2A receptor antagonists in Parkinson's disease. Pharmacol Ther 105:267-310.
500. Yamada T and Chakrabarty AM (2004) ATP-utilizing enzymes, purinergic recerptor modulation, cupredoxins and mammalian cell death, in Pseudomonas (Ramos J-L ed) pp 47-67, Kluwer Academic, New York.
501. i during adenosine triphosphate-induced synaptic plasticity in hippocampal CA1 neurons of the guinea pig. Neurosci Lett 324:65-68.
502. 4 receptors in heart failure: rescue of the calsequestrin overexpression model of cardiomyopathy. Am J Physiol 287:H1096-H1103.
503. 2 receptor subunit immunoreactivity on nitric oxide synthase expressing neurones in the brain stem and hypothalamus of the rat: a fluorescence immunohistochemical study. Neuroscience 121:411-419.
504. Yerxa BR (2001) Therapeutic use of nucleotides in respiratory and ophthalmic diseases. Drug Dev Res 52:196-201.
505. 2 receptor agonist for the treatment of cystic fibrosis. J Pharmacol Exp Ther 302:871-880.
506. 3 is increased in human inflammatory bowel disease. Neurogastroenterol Motil 13:365-369.
507. Yoshida M, Homma Y, Inadome A, Yono M, Seshita H, Miyamoto Y, Murakami S, Kawabe K, and Ueda S (2001) Age-related changes in cholinergic and purinergic neurotransmission in human isolated bladder smooth muscles. Exp Gerontol 36: 99-109.
508. Yoshida M, Miyamae K, Iwashita H, Otani M, and Inadome A (2004) Management of detrusor dysfunction in the elderly: changes in acetylcholine and adenosine triphosphate release during aging. Urology 63:17-23.
509. Yu Y and de Groat WC (2004) Sensitization of pelvic afferent nerves in the in vitro urinary bladder - pelvic nerve preparation of the rat by purinergic agonists or by cyclophosphamide (CYP) pre-treatment, in 2004 Abstract Viewer/Itinerary Planner; Program no. 541.3. Society for Neuroscience, Washington, DC.
510. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, and Fox KK (2001) Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 345:494-502.
511. Zablocki J, Kalla R, Perry T, Palle V, Varkhedkar V, Xiao D, Piscopio A, Maa T, Gimbel A, Hao J, et al. (2005) The discovery of a selective, high
512. 2/M arrest and mitotic catastrophe. Neoplasia 6:802-812.
513. Zhang JM, Wang HK, Ye CQ, Ge W, Chen Y, Jiang ZL, Wu CP, Poo MM, and Duan S (2003) ATP released by astrocytes mediates glutamatergic activity-dependent heterosynaptic suppression. Neuron 40:971-982.
514. Zhang S, Remillard CV, Fantozzi I, and Yuan JX-J (2004b) ATP-induced mitogenesis is mediated by cyclic AMP response element-binding protein-enhanced TRPC4 expression and activity in human pulmonary artery smooth muscle cells. Am J Physiol 287:C1192-C1201.
515. 7 in human hematpoietic cell lines and leukaemia patients. Leuk Res 28:1313-1322.
516. Zhao DM, Xue HH, Chida K, Suda T, Oki Y, Kanai M, Uchida C, Ichiyama A, and Nakamura H (2000) Effect of erythromycin on ATP-induced intracellular calcium response in A549 cells. Am J Physiol 278:L726-L736.
517. Zhu CZ, Mikusa J, Chu KL, Cowart M, Kowaluk EA, Jarvis MF, and McGaraughty S (2001) A-134974: a novel adenosine kinase inhibitor, relieves tactile allodynia via spinal sites of action in peripheral nerve injured rats. Brain Res 905:104-110.
518. Zimmermann H (2001) Ectonucleotidases: some recent developments and a note on nomenclature. Drug Dev Res 52:44-56.
519. Zona C, Marchetti C, Volontè C, Mercuri NB, and Bernardi G (2000) Effect of P2 purinoceptor antagonists on kainate-induced currents in rat cultured neurons. Brain Res 882:26-35.
520. Zsembery A, Boyce AT, Liang L, Peti-Peterdi J, Bell PD, and Schwiebert EM (2003) Sustained calcium entry through P2X nucleotide receptor channels in human airway epithelial cells. J Biol Chem 278:13398-13408.